Roger Taylor

Title: The Innovations of Roger Taylor

Introduction

Roger Taylor is a notable inventor based in Leeds, GB. He has made significant contributions to the field of medical science, particularly in the development of anticoagulants. His work focuses on the modulation of Factor XII, which plays a crucial role in the blood coagulation process.

Latest Patents

Roger Taylor holds a patent for Factor XIIA inhibitors. This invention relates to compounds of formula (I) and methods of treatment using these compounds. The compounds are designed to be modulators of Factor XII, specifically acting as inhibitors of Factor XIIa. This innovation may prove useful as anticoagulants, providing new avenues for treatment in patients at risk of thrombotic events.

Career Highlights

Roger Taylor is affiliated with the University of Leeds, where he conducts his research and development work. His academic background and ongoing research contribute to advancements in medical treatments and therapies.

Collaborations

Some of his notable coworkers include Helen Philippou and Richard James Foster. Their collaborative efforts enhance the research environment and foster innovation within their projects.

Conclusion

Roger Taylor's contributions to the field of medical science through his patent on Factor XIIA inhibitors highlight the importance of innovation in developing new treatments. His work at the University of Leeds continues to pave the way for advancements in anticoagulant therapies.